Pipex's Zinthionein meets dry AMD endpoint

Pipex (AMEX:PP) said 25 mg of oral Zinthionein (formerly Z-Monocys) twice daily for six months met the primary endpoint of a significant improvement in visual acuity vs. placebo (p<0.0001) in a Phase ...